Securities code: 002382 securities abbreviation: Blue Sail Medical Co.Ltd(002382) Announcement No.: 2022-007 bond Code: 128108 bond abbreviation: lanfan convertible bond
Blue Sail Medical Co.Ltd(002382)
Announcement on the chairman no longer serving as president and appointing president
The company and all members of the board of directors guarantee that the information disclosed is true, accurate and complete without false records, misleading statements or major omissions.
1、 On the situation that Ms. Liu Wenjing no longer holds the post of President
Blue Sail Medical Co.Ltd(002382) (hereinafter referred to as “the company”) recently received a written resignation report from Ms. Liu Wenjing, the chairman and President of the company, on her application to no longer hold the post of president. Considering the company’s long-term strategic inheritance, incremental business development and the age echelon construction of the company’s management team, Ms. Liu Wenjing applied to no longer hold the post of president. After resigning as president, Ms. Liu Wenjing will continue to serve as chairman of the company, chairman of the strategy committee, member of the nomination committee and member of the remuneration and assessment committee, and will focus more on the overall development strategic layout of the company and explore new space for high-quality development.
In accordance with the provisions of the company law of the people’s Republic of China (hereinafter referred to as the “company law”) and the Blue Sail Medical Co.Ltd(002382) articles of Association (hereinafter referred to as the “articles of association”), Ms. Liu Wenjing’s resignation report shall take effect from the date of serving on the board of directors. During her concurrent term as president, Ms. Liu Wenjing was diligent and responsible, led the company to continuously break through itself, transformation and upgrading, and played a core role in the company’s operation and development. The board of directors of the company expressed heartfelt thanks to Ms. Liu Wenjing for her outstanding contribution to the development of the company.
As of the disclosure date of this announcement, Ms. Liu Wenjing holds 3083400 shares of the company, accounting for 0.31% of the total share capital of the company. Ms. Liu Wenjing has promised not to reduce her shares of the company within 6 months from the date of completion of her increase in shares of the company. The above commitments have not been fulfilled and there is no breach of commitments. After Ms. Liu Wenjing no longer holds the post of president, her shares of the company will continue to be held in strict accordance with relevant laws and regulations such as the stock listing rules of Shenzhen Stock Exchange, the guidelines for the standardized operation of listed companies of Shenzhen Stock Exchange, and the detailed rules for the implementation of share reduction by shareholders, directors, supervisors and senior managers of listed companies of Shenzhen Stock Exchange Share management shall be carried out in accordance with the provisions of normative documents.
2、 Appointment of Mr. Zhong Shuqiao as president of the company
In order to ensure the normal development of the company’s production and operation, upon the nomination of the chairman of the company and the review of the nomination committee of the board of directors, the company held the 21st Meeting of the Fifth Board of directors on January 13, 2022, reviewed and approved the proposal on the appointment of the president of the company, and agreed to appoint Mr. Zhong Shuqiao as the president of the company, The term of office starts from the date of deliberation and approval by the board of directors of the company to the date of expiration of the term of office of the Fifth Board of directors. After taking office as the president of the company, Mr. Zhong Shuqiao will no longer serve as the vice president and chief capital officer of the company. He will continue to serve as a director and concurrently as the Secretary of the board of directors until the Company re appoints the Secretary of the board of directors. Mr. Zhong Shuqiao’s qualifications comply with the provisions of relevant laws and regulations, and there is no situation that he is not allowed to serve as a senior manager of the company as stipulated in the company law, the guidelines for the standardized operation of listed companies of Shenzhen Stock Exchange and the articles of association. The independent directors of the company expressed their independent opinions on the proposal of appointing the president.
In the past 20 years since its establishment, the company has closely followed the changes of economic situation and market environment, always emphasized innovation and development, constantly explored business upgrading, built a high-quality development platform, gathered a large number of professional business elites, and grown a number of brave, young and promising new generation managers. Mr. Zhong Shuqiao has served as the director, vice president and chief capital officer of the company since September 2018 and the Secretary of the board of directors since October 2018. He has led the company’s key businesses such as major asset restructuring, overseas M & A, convertible corporate bonds and the preparation and development of new business division. He is not only familiar with the company’s development strategy, corporate culture and organizational system, but also brave in exploration and innovation Enterprising and entrepreneurial, with professional background and practical experience in strategic operation, capital operation, corporate governance and the combination of industry and capital, meets the needs of the company to carry forward the past and forge ahead, further improve business development and comprehensive competitiveness. In the future, the company’s management will continue to inject fresh blood, maintain entrepreneurial vitality, and continue to inherit the enterprise values of openness, inclusiveness, standardization and co creation on the basis of existing business platforms and rich resource endowments, so as to promote the company to a higher level. See the attachment for the resume of Mr. Zhong Shuqiao.
It is hereby announced.
Blue Sail Medical Co.Ltd(002382)
Board of directors
January 14, 2002
enclosure:
Resume of Mr. Zhong Shuqiao
Mr. Zhong Shuqiao, born in July 1985, Chinese nationality, without overseas residency, master of finance, Peking University. He once worked in the M & a business line of Citic Securities Company Limited(600030) Investment Banking Committee and the investment banking department of Morgan Stanley Huaxin Securities Co., Ltd., and has the qualification of sponsor representative. At present, he is the director, President and Secretary of the board of directors of the company. He also serves as the chairman of lanfan surgical instruments Co., Ltd., the director of Zibo lanfan Investment Co., Ltd., the director of biosensors interactive technologies Pte.Ltd., and the director of CB cardio holdings II Limited.
Mr. Zhong Shuqiao holds 255000 shares of the company, accounting for 0.03% of the total share capital of the company. Except as a director of Zibo lanfan Investment Co., Ltd., the controlling shareholder of the company, he has no relationship with other shareholders holding more than 5% of the company’s shares, actual controllers, other directors, supervisors and senior managers. In the past three years, he has not been punished by the CSRC and other relevant departments or disciplined by the stock exchange, has not been placed on file for investigation by judicial organs for suspected crimes or by the CSRC for suspected violations of laws and regulations, has not been prohibited from entering the securities market by the CSRC, and has not been prohibited from serving as a director or supervisor of the company as stipulated in the company law and the articles of association Senior management. At the same time, after the company’s verification on the website of the Supreme People’s court, Mr. Zhong Shuqiao does not belong to the person subject to execution for dishonesty.
